Risk factor
Weak & very vulnerable to price shocks
Profitability factor
Very low or no dividends
About
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising Practice Management software, AI Patient Scheduling Software, and Electronic Statements and Payments; revenue cycle management solutions, including Revenue Cycle Services and revenue cycle management...
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EB
Target Price
The average target price of MDRX is 4.6 and suggests 3% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation su
Buy
Sell